Recommendations for breast cancer surveillance for female survivors of childhood, adolescent, and young adult cancer given chest radiation: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group.

[1]  H. Caron,et al.  A worldwide collaboration to harmonize guidelines for the long‐term follow‐up of childhood and young adult cancer survivors: A report from the international late effects of Childhood Cancer Guideline Harmonization Group , 2013, Pediatric blood & cancer.

[2]  D. Altman,et al.  The benefits and harms of breast cancer screening: an independent review , 2012, British Journal of Cancer.

[3]  David Evans,et al.  Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RISK) , 2012, British medical journal.

[4]  Trudy van der Weijden,et al.  Clinical practice guidelines and patient decision aids. An inevitable relationship. , 2012, Journal of clinical epidemiology.

[5]  H. D. de Koning,et al.  Tipping the Balance of Benefits and Harms to Favor Screening Mammography Starting at Age 40 Years , 2012, Annals of Internal Medicine.

[6]  Ellen Warner,et al.  Clinical practice. Breast-cancer screening. , 2011, The New England journal of medicine.

[7]  E. Elkin,et al.  Characteristics and outcomes of breast cancer in women with and without a history of radiation for Hodgkin's lymphoma: a multi-institutional, matched cohort study. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  Laura Cortesi,et al.  Multicenter Surveillance of Women at High Genetic Breast Cancer Risk Using Mammography, Ultrasonography, and Contrast-Enhanced Magnetic Resonance Imaging (the High Breast Cancer Risk Italian 1 Study): Final Results , 2011, Investigative radiology.

[9]  C. Lemanski,et al.  Ductal carcinoma in situ of the breast in younger women: a subgroup of patients at high risk. , 2010, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[10]  H. Sugiyama,et al.  Relationship between radiation exposure and risk of second primary cancers among atomic bomb survivors. , 2010, Cancer research.

[11]  Melissa M. Hudson,et al.  Systematic Review: Surveillance for Breast Cancer in Women Treated With Chest Radiation for Childhood, Adolescent, or Young Adult Cancer , 2010, Annals of Internal Medicine.

[12]  R. Kane,et al.  Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes. , 2010, Journal of the National Cancer Institute.

[13]  A. Broeks,et al.  Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  L. Robison,et al.  Radiation dose and breast cancer risk in the childhood cancer survivor study. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  A. Howell,et al.  The UK national breast cancer screening programme for survivors of Hodgkin lymphoma detects breast cancer at an early stage , 2009, British Journal of Cancer.

[16]  J. Coebergh,et al.  Survival of European children and young adults with cancer diagnosed 1995-2002. , 2009, European journal of cancer.

[17]  G. Oster,et al.  Cost effectiveness of breast cancer screening with contrast-enhanced MRI in high-risk women. , 2009, Journal of the American College of Radiology : JACR.

[18]  Mark Robson,et al.  Estimated risk of radiation-induced breast cancer from mammographic screening for young BRCA mutation carriers. , 2009, Journal of the National Cancer Institute.

[19]  D. Plewes,et al.  Systematic Review: Using Magnetic Resonance Imaging to Screen Women at High Risk for Breast Cancer , 2008, Annals of Internal Medicine.

[20]  C. Stiller,et al.  Second primary neoplasms in survivors of Wilms' tumour—A population‐based cohort study from the British Childhood Cancer Survivor Study , 2008, International Journal of Cancer.

[21]  W. Leisenring,et al.  Increased risk of breast cancer among survivors of allogeneic hematopoietic cell transplantation: a report from the FHCRC and the EBMT-Late Effect Working Party. , 2008, Blood.

[22]  C. Begg,et al.  Variation of breast cancer risk among BRCA1/2 carriers. , 2008, JAMA.

[23]  N Houssami,et al.  A systematic review of the effectiveness of magnetic resonance imaging (MRI) as an addition to mammography and ultrasound in screening young women at high risk of breast cancer. , 2007, European journal of cancer.

[24]  Monique W M Jaspers,et al.  Medical assessment of adverse health outcomes in long-term survivors of childhood cancer. , 2007, JAMA.

[25]  J. Otten,et al.  Cost-effectiveness of different reading and referral strategies in mammography screening in the Netherlands , 2007, Breast Cancer Research and Treatment.

[26]  D. Easton,et al.  The cost-utility of magnetic resonance imaging for breast cancer in BRCA1 mutation carriers aged 30–49 , 2007, The European Journal of Health Economics.

[27]  C. Stiller,et al.  Risk of breast cancer in female survivors of childhood Hodgkin's disease in Britain: A population‐based study , 2007, International journal of cancer.

[28]  A. Goldhirsch,et al.  Breast cancer in Hodgkin's disease and non-Hodgkin's lymphoma survivors. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[29]  Kevin C Oeffinger,et al.  Chronic health conditions in adult survivors of childhood cancer. , 2006, The New England journal of medicine.

[30]  A R Padhani,et al.  Cost-effectiveness of screening with contrast enhanced magnetic resonance imaging vs X-ray mammography of women at a high familial risk of breast cancer , 2006, British Journal of Cancer.

[31]  H. D. de Koning,et al.  Factors Affecting Sensitivity and Specificity of Screening Mammography and MRI in Women with an Inherited Risk for Breast Cancer , 2006, Breast Cancer Research and Treatment.

[32]  Bruce L Daniel,et al.  Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging. , 2006, JAMA.

[33]  J. Elmore,et al.  Screening clinical breast examination: how often does it miss lethal breast cancer? , 2005, Journal of the National Cancer Institute. Monographs.

[34]  M. Gail,et al.  Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma. , 2005, Journal of the National Cancer Institute.

[35]  A R Padhani,et al.  Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS) , 2005, The Lancet.

[36]  K C Young,et al.  Radiation doses received in the UK Breast Screening Programme in 2001 and 2002. , 2005, The British journal of radiology.

[37]  Emily White,et al.  The incremental contribution of clinical breast examination to invasive cancer detection in a mammography screening program. , 2005, AJR. American journal of roentgenology.

[38]  D. Green,et al.  Development of risk-based guidelines for pediatric cancer survivors: the Children's Oncology Group Long-Term Follow-Up Guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[39]  L. Robison,et al.  Breast Cancer after Childhood Cancer: A Report from the Childhood Cancer Survivor Study , 2004, Annals of Internal Medicine.

[40]  Ellen Warner,et al.  Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination , 2004, JAMA.

[41]  H. D. de Koning,et al.  Decreased rates of advanced breast cancer due to mammography screening in The Netherlands , 2004, British Journal of Cancer.

[42]  H. D. de Koning,et al.  Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. , 2004, The New England journal of medicine.

[43]  M. Fay.  Estimating age conditional probability of developing disease from surveillance data , 2004, Population health metrics.

[44]  G. Guyatt,et al.  Grading quality of evidence and strength of recommendations , 2004, BMJ : British Medical Journal.

[45]  L. Robison,et al.  High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: report from the Late Effects Study Group. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[46]  S. Parkes,et al.  Caring for survivors of childhood cancers: the size of the problem. , 2006, European journal of cancer.

[47]  H. D. de Koning,et al.  Mammographic screening: evidence from randomised controlled trials. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[48]  M. Stovall,et al.  Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. , 2003, JAMA.

[49]  A. Broeks,et al.  Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease. , 2003, Journal of the National Cancer Institute.

[50]  Eric J Feuer,et al.  Age‐conditional probabilities of developing cancer , 2003, Statistics in medicine.

[51]  J. Hendriks,et al.  Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review , 2003, The Lancet.

[52]  Erik Holmberg,et al.  Radiation Effects on Breast Cancer Risk: A Pooled Analysis of Eight Cohorts , 2002, Radiation research.

[53]  D. Neuberg,et al.  Breast cancer screening in women previously treated for Hodgkin's disease: a prospective cohort study. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[54]  C. Borel,et al.  Breast cancer occurred after treatment for Hodgkin's disease: analysis of 133 cases. , 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[55]  L Duchateau,et al.  Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[56]  C. Shapiro,et al.  Clinical and Pathologic Features of Breast Cancers in Women Treated for Hodgkin's Disease: A Case‐Control Study , 2001, The breast journal.

[57]  N. Lee,et al.  Findings from 752,081 clinical breast examinations reported to a national screening program from 1995 through 1998. , 2000, Journal of the National Cancer Institute.

[58]  H. Storm,et al.  Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[59]  K C Young,et al.  Radiation doses received in the UK Breast Screening Programme in 1997 and 1998. , 2000, The British journal of radiology.

[60]  S. Jeffrey,et al.  Management of breast cancer after Hodgkin's disease. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[61]  J. Grimshaw,et al.  Potential benefits, limitations, and harms of clinical guidelines , 1999, BMJ.

[62]  J. Grimshaw,et al.  Getting research findings into practice: Closing the gap between research and practice: an overview of systematic reviews of interventions to promote the implementation of research findings , 1998 .

[63]  J. Elmore,et al.  Ten-year risk of false positive screening mammograms and clinical breast examinations. , 1998, The New England journal of medicine.

[64]  J Chang-Claude,et al.  Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. , 1998, American journal of human genetics.

[65]  D E Goldgar,et al.  Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13. , 1997, American journal of human genetics.

[66]  J. Grimshaw,et al.  Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations , 1993, The Lancet.

[67]  D. Dershaw,et al.  Breast cancer in patients irradiated for Hodgkin's disease: a clinical and pathologic analysis of 45 events in 37 patients. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[68]  D. Dershaw,et al.  Breast carcinoma in women previously treated for Hodgkin disease: mammographic evaluation. , 1992, Radiology.

[69]  S. Greenfield,et al.  Clinical practice guidelines we can trust , 2011 .

[70]  W. Wallace,et al.  Long-term follow-up of survivors of childhood cancer. , 2009, Endocrine development.

[71]  D. Ikeda,et al.  Mammographic Screening in Women at Increased Risk of Breast Cancer after Treatment of Hodgkin’s Disease , 2008, The breast journal.

[72]  P. Goss,et al.  Screening mammography for young women treated with supradiaphragmatic radiation for Hodgkin's lymphoma. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[73]  M. Mathieu,et al.  Malignant breast tumors after radiotherapy for a first cancer during childhood. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[74]  E. Antman,et al.  American College of Cardiology/American Heart Association clinical practice guidelines: Part I: where do they come from? , 2003, Circulation.

[75]  D. Easton,et al.  Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. , 1995, American journal of human genetics.